Pfizer’s product pipeline is a summary of the investigational medicines and vaccines that we’re currently researching and testing, but it can mean so much more. Here’s what it is and why you should care.
People in the US, and around the globe, are increasingly falling victim to counterfeit drugs sold illegally online. The World Health Organization estimates that one million people die annually from taking fake or substandard medicines.
Pfizer and BioNTech’s embrace of novel mRNA science played a pivotal role in achieving a record-breaking COVID-19 vaccine rollout. But a lesser-known part of this success story is Pfizer’s rapid adoption of new digital technologies to ensure the vaccine reached patients as safely and quickly as possible.
In the spring of 2021, months before Pfizer’s COVID-19 vaccine would receive emergency use authorization, Pfizer scientists, engineers, and manufacturing experts were already thinking ahead to last-mile communities like those in Ghana’s rural Ashanti region. They knew that providing access to COVID-19 vaccines to every human on the planet would be challenging, but an absolute necessity.
How do scientific discoveries move from the lab to our pharmacy shelves? This journey is known as drug development, and clinical trials are a key part of the process. In fact, without these research studies, we would have no new medicines or vaccines.
Scientists are often lauded for their objectivity, persistence, and analytic thinking. But great scientists have something else in common: they think like artists. And for those who create life-changing medicines, their process is as much an art form as a science.